Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Cell Trials Data is not a typical online course platform, but a clinical trial dataset store focused on niche areas within life sciences. Its pages list products such as exosome clinical trials, in vivo gene therapy trials, MSC clinical trials, cell and gene therapy CMO/CDMO facilities, cord blood banks, and psychedelic psychiatry clinical research. The main delivery format is “searchable and sortable Excel spreadsheets,” with some sample files and free datasets available.
From an education/course perspective, it does not offer live classes, recorded lessons, 1-on-1 tutoring, assignments, or a structured learning path, nor does it display any completion certificates. Its value lies in the structured data itself. For example, the exosome database covers 444 trials from 2011 to 2025 plus 24 related publications, screened according to the ISEV/MISEV2018 definition. The gene therapy database covers 879 in vivo gene therapy trials from 2011 to 2021 and notes that 66,867 candidate trials were manually screened. Fields include registration date, country, phase, status, route of administration, dosage, indication, patient age group, sponsor, product name, publications, and more, making it suitable for research and industry analysis.
The commercial datasets are relatively expensive, with listed prices ranging from US$500 to US$1,550: the exosome dataset costs US$1,550, gene therapy US$900, 4.5 years of MSC data US$1,250, and CMO/CDMO facilities US$700. There is also a free COVID-19 cell therapy trials dataset, academic datasets free for researchers, and custom datasets with negotiable pricing. If used for competitive intelligence, literature reviews, or BD screening, it can save manual search costs; if the goal is only beginner-level learning, the value for money is not high.
Its strengths are its vertical domain focus, relatively clear data boundaries and screening criteria, and Excel format that makes secondary analysis easy. The exosome data also notes that only about 2% of keyword-matched candidate trials met its inclusion criteria, reflecting a degree of manual curation value. The downsides are that it is not a course product and lacks explanations, teaching support, certificates, and a learning community. The website does not clarify payment methods, after-sales support, or update mechanisms. Some scraped content includes Excel encoding artifacts, making the information presentation less user-friendly.
It is suitable for researchers, industry analysts, pharma BD teams, and academic review authors working in cell therapy, gene therapy, exosomes, MSCs, and related fields. It is not suitable for absolute beginners or users who need Chinese-language courses or exam-based certification. Access from China cannot be determined from the available text, and payment methods are not disclosed. Alternatives include ClinicalTrials.gov, WHO ICTRP, the EU Clinical Trials Register, and commercial life sciences databases.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on celltrialsdata.net official site.
celltrialsdata.net is an Unknown Education provider. TG4G tracks its product information, with monthly pricing from $1,550.00, an overall rating of 7.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach celltrialsdata.net directly.